DOI QR코드

DOI QR Code

Hospitalization Risk According to Geriatric Assessment and Laboratory Parameters in Elderly Hematologic Cancer Patients

  • Silay, Kamile (Department of Geriatrics, Ataturk Research and Training Hospital, Faculty of Medicine, Yildirim Beyazit University) ;
  • Akinci, Sema (Department of Hematology, Ataturk Research and Training Hospital, Faculty of Medicine, Yildirim Beyazit University) ;
  • Silay, Yavuz Selim (Association of Research-Based Pharmaceutical Companies (AIFD), Nonprofit Organization) ;
  • Guney, Tekin (Department of Hematology, Ataturk Research and Training Hospital, Faculty of Medicine, Yildirim Beyazit University) ;
  • Ulas, Arife (Department of Oncology, Ataturk Research and Training Hospital, Faculty of Medicine, Yildirim Beyazit University) ;
  • Akinci, Muhammed Bulent (Internal Medicine, Ataturk Research and Training Hospital, Faculty of Medicine, Yildirim Beyazit University) ;
  • Ozturk, Esin (Department of Family Medicine, Ataturk Research and Training Hospital, Faculty of Medicine, Yildirim Beyazit University) ;
  • Canbaz, Merve (Department of Family Medicine, Ataturk Research and Training Hospital, Faculty of Medicine, Yildirim Beyazit University) ;
  • Yalcin, Bulent (Internal Medicine, Ataturk Research and Training Hospital, Faculty of Medicine, Yildirim Beyazit University) ;
  • Dilek, Imdat (Internal Medicine, Ataturk Research and Training Hospital, Faculty of Medicine, Yildirim Beyazit University)
  • Published : 2015.02.25

Abstract

Background: Utilizing geriatric screening tools for the identification of vulnerable older patients with cancer is important. The aim of this study is to evaluate the hospitalization risk of elderly hematologic cancer patients based on geriatric assessment and laboratory parameters. Materials and Methods: In this cross sectional study 61 patients with hematologic malignancies, age 65 years and older, were assessed at a hematology outpatient clinic. Standard geriatric screening tests; activities of daily living (ADL), instrumental activities of daily living (IADL), Mini Nutritional Assessment (MNA), Mini Mental State Examination (MMSE), timed up and go test (TUG), geriatrics depression scale (GDS) were administered. Demographic and medical data were obtained from patient medical records. The number of hospitalizations in the following six months was then recorded to allow analysis of associations with geriatric assessment tools and laboratory parameters. Results: The median age of the patients, 37 being males, was 66 years. Positive TUG test and declined ADL was found as significant risk factors for hospitalization (p=0.028 and p=0.015 respectively). Correlations of hospitalization with thrombocytopenia, vitamin B12 and folic acid deficiency were statistically significant (p=0.004, p=0.011 and p=0.05 respectively). Conclusions: In this study, geriatric conditions which are usually unrecognized in a regular oncology office visit were identified. Our study indicates TUG and ADL might be use as predictive tests for hospitalization in elderly oncology populations. Also thrombocytopenia, and vitamin B12 and folic acid deficiencies are among the risk factors for hospitalization. The importance of vitamin B12 and folic acid vitamin replacement should not be underestimated in this population.

References

  1. Allepaerts S, De Flines J, Paquot N (2014). Nutrition in the elderly. Rev Med Liege, 69, 244-50.
  2. Castellon TD, Sieving KE (2006). An experimental test of matrix permeability and corridor use by an endemic understory bird. Conserv Biol, 20, 135-45. https://doi.org/10.1111/j.1523-1739.2006.00332.x
  3. Chiang-Hanisko L, Tan JY, Chiang LC (2014). Polypharmacy issues in older adults. Hu Li Za Zhi, 61, 97-104.
  4. Decoster K, Van Puyvelde S, Mohile U, et al (2014). Extermann Screening tools for multidimensional health problems warranting a geriatric assessment in older cancer patients: an update on SIOG recommendations; An Oncol Advance, Access published June 16,
  5. Devons CA (2002). Comprehensive geriatric assessment: making the most of the aging years. Curr Opin Clin Nutr Metab Care, 5, 19-24. https://doi.org/10.1097/00075197-200201000-00004
  6. Extermann M, Hurria A (2007). Comprehensive geriatric assessment for older patients with cancer. J Clin Oncol, 25, 1824-31. https://doi.org/10.1200/JCO.2007.10.6559
  7. Extermann M, Aapro M, Bernabei R, et al (2005). Use of comprehensive geriatric assessment in older cancer patients: recommendations from the task force on CGA of the international society of geriatric oncology (SIOG). Crit Rev Oncol Hematol, 55, 241-52. https://doi.org/10.1016/j.critrevonc.2005.06.003
  8. Extermann M, Boler I, Reich RR, et al (2012). Predicting the risk of chemotherapy toxicity in older patients: the chemotherapy risk assessment scale for high-age patients (CRASH) score. Cancer, 118, 3377-86. https://doi.org/10.1002/cncr.26646
  9. Grabowski DC, Ellis JE (2001). High body mass index does not predict mortality in older people: analysis of the longitudinal study of aging. J Am Geriatr Soc, 49, 968. https://doi.org/10.1046/j.1532-5415.2001.49189.x
  10. Hamaker ME, Prins MC, Stauder R (2014). The relevance of a geriatric assessment for elderly patients with a haematological malignancy-a systematic review. Leuk Res, 38, 275-83. https://doi.org/10.1016/j.leukres.2013.12.018
  11. Hurria A, Togawa K, Mohile SG, et al (2011). Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study. J Clin Oncol, 29, 3457-65. https://doi.org/10.1200/JCO.2011.34.7625
  12. Katon WJ (2003). Clinical and health services relationships between major depression, depressive symptoms, and general medical illness. Biol Psychiatry, 54, 216-26. https://doi.org/10.1016/S0006-3223(03)00273-7
  13. Khoei MA, Akbari ME, Sharifi F, Fakhrzadeh H, Larijani B (2013). Translation and validation of the activities of daily living scale with Iranian elderly cancer patients treated in an oncology unit. Asian Pac J Cancer Prev, 14, 2731-7. https://doi.org/10.7314/APJCP.2013.14.5.2731
  14. Kua J (2005). The prevalence of psychological and psychiatric sequelae of cancer in the elderly-how much do we know? Ann Acad Med Singapore, 34, 250-6.
  15. Landi F, Onder G, Gambassi G, et al (2000). Body mass index and mortality among hospitalized patients. Arch Intern Med, 160, 2641-4. https://doi.org/10.1001/archinte.160.17.2641
  16. Lichtman SM, Villani G (2000). Chemotherapy in the elderly: pharmacologic considerations. Cancer Control, 7, 548.
  17. Lichtman SM (2006). Therapy insight: therapeutic challenges in the treatment of elderly cancer patients. Nat Clin Pract Oncol, 3, 86-93. https://doi.org/10.1038/ncponc0420
  18. Maggiore RJ, Dale W, Gross CP, et al (2014). Polypharmacy and potentially inappropriate medication use in older adults with cancer undergoing chemotherapy: effect on chemotherapyrelated toxicity and hospitalization during treatment. J Am Geriatr Soc, 62, 1505-12. https://doi.org/10.1111/jgs.12942
  19. Newman AB, Yanez D, Harris T, et al (2001). Weight change in old age and its association with mortality. J Am Geriatr Soc, 49, 1309-18. https://doi.org/10.1046/j.1532-5415.2001.49258.x
  20. Razali RM, Bee PC, Gan GG (2013). Survey of willingness to accept chemotherapy among elderly Malaysian patients. Asian Pac J Cancer Prev, 14, 2029-32. https://doi.org/10.7314/APJCP.2013.14.3.2029
  21. Repetto L, Fratino L, Audisio RA, et al (2002). Comprehensive geriatric assessment adds information to Eastern cooperative oncology group performance status in elderly cancer patients: an Italian group for geriatric oncology study. J Clin Oncol, 20, 494-502. https://doi.org/10.1200/JCO.20.2.494
  22. Reynolds MW, Fredman L, Langenberg P, Magaziner J (1999). Weight, weight change, mortality in a random sample of older community-dwelling women. J Am Geriatr Soc, 47, 1409-14. https://doi.org/10.1111/j.1532-5415.1999.tb01558.x
  23. Stuck AE, Siu AL, Wieland GD, et al (1993). Comprehensive geriatric assessment: a meta-analysis of controlled trials. Lancet, 342, 1032-6. https://doi.org/10.1016/0140-6736(93)92884-V
  24. Vestal RE (1997). Aging and pharmacology. Cancer, 80, 1302-10. https://doi.org/10.1002/(SICI)1097-0142(19971001)80:7<1302::AID-CNCR16>3.0.CO;2-B
  25. Vinokur AD, Threatt BA, Vinokur-Kaplan D, Satariano WA (1990). The process of recovery from breast cancer for younger and older patients. changes during the first year. Cancer, 65, 1242-54. https://doi.org/10.1002/1097-0142(19900301)65:5<1242::AID-CNCR2820650535>3.0.CO;2-1
  26. Wallace JI, Schwartz RS, LaCroix AZ, et al (1995). Involuntary weight loss in older outpatients: incidence and clinical significance. J Am Geriatr Soc, 43, 329-37. https://doi.org/10.1111/j.1532-5415.1995.tb05803.x
  27. Welch HG, Albertsen PC, Nease RF, et al (1996). Estimating treatment benefits for the elderly: the effect of competing risks. Ann Intern Med, 124, 577-84. https://doi.org/10.7326/0003-4819-124-6-199603150-00007
  28. Wolfson C, Wolfson DB, Asgharian M, et al (2001). A reevaluation of the duration of survival after the onset of dementia. N Engl J Med, 344, 1111-6. https://doi.org/10.1056/NEJM200104123441501
  29. Yancik R, Ries LA (2004). Cancer in older persons: an international issue in an aging world. Semin Oncol, 31, 128-36. https://doi.org/10.1053/j.seminoncol.2003.12.024

Cited by

  1. Polypharmacy in Older Adults with Cancer: Evaluating Polypharmacy as Part of the Geriatric Assessment vol.6, pp.4, 2017, https://doi.org/10.1007/s13670-017-0221-1
  2. What Every Oncologist Should Know About Geriatric Assessment for Older Patients With Cancer: Young International Society of Geriatric Oncology Position Paper vol.14, pp.2, 2018, https://doi.org/10.1200/JOP.2017.026435
  3. Nutritional Interventions for Treating Cancer-Related Fatigue: A Qualitative Review pp.1532-7914, 2019, https://doi.org/10.1080/01635581.2018.1513046